摘要:
The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.
摘要:
A multi-use washcloth made for retaining a bar of soap or shower gel for use in the bath or shower and assist the user from dropping the soap bar and wastage of the soap. Furthermore it can be used as an ice pack, and cosmetic bag. The washcloth is fabricated from soft porous and flexible cut into predetermined lengths and widths and stitched together on three sides and open fourth end forming a simple bag. At the opening of the bag a hook-and-loop fasteners are stitched to the two sides of the open ends. Hence it helps to retain the products (such as soap bar, shower gel, ice and cosmetics) whenever the wash cloth is being used in the various ways.
摘要:
A method of synthesizing a compound of formula I: comprising the step of reacting a moiety of formula II: with a moiety of formula III: in compressed carbon dioxide in the presence of a transition metal catalyst and a base, wherein L is a labile leaving group; RN1 is optionally substituted C5-20 aryl; RN2 is selected from optionally substituted C5-20aryl, optionally substituted C3-20 heterocyclyl, optionally substituted C3-7 alkyl, and optionally substituted sulfonyl; RN3 is selected from H and optionally substituted C1-7 alkyl, C3-20 heterocyclyl and C5-20 aryl; or RN2 and RN3 together with the nitrogen atom to which they are attached form optionally substituted nitrogen-containing C3-20 heterocylyl or C5-20 heteroaryl; and R1 R2 and R3 are independently selected from optionally substituted C1-7 alkyl, C5-20 aryl, C3-20 heterocyclyl, hydroxy, halo, amino and C1-7 alkoxy, or two of R1, R2 and R3, together with the silicon atom to which they are attached, may form a silicon containing C5-7 heterocyclyl group.
摘要翻译:合成式I化合物的方法:包括使式II部分与式III部分反应的步骤:在过渡金属催化剂和碱的存在下,在压缩二氧化碳中,其中L是不稳定的离去 组; R 01是任选取代的C 5-20芳基; R N2选自任选取代的C 5-20芳基,任选取代的C 3-20杂环基,任选取代的C 3-8芳基, 7烷基和任选取代的磺酰基; R N 3选自H和任选取代的C 1-7 - 烷基,C 3-20 - 杂环基和C 5-20杂环基, / SUB>芳基; 或R N2和R N3与它们所连接的氮原子一起形成任选取代的含氮C 3-20异氰酸酯或C 5-20杂芳基; R 1和R 3独立地选自任选取代的C 1-7烷基,C 1 -C 6烷基, 羟基,卤素,氨基和C 1-7 - 烷氧基,或者R 1,R 2,R 2, 1,R 2和R 3与它们所连接的硅原子一起可以形成含有C 5-7的硅, / SO 2杂环基。
摘要:
The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.
摘要:
A novel compound 4H-indeno[4,5-D]-1,3-dioxole, 3A,5,6,7,8,8B-hexahydro-2,2,6,6,7,8,8-heptamethyl is dislosed as well as the use of the compound as a fragrance chemical. The fragrance compound is suitable for use in creating fragrances, and scents in items such as perfumes, colognes and personal care products.
摘要:
The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-α synthesis; iii) an inhibitor of membrane-bound TNF-α; iv) an inhibitor of a natural receptor of TNF-α; v) an inhibitor of NO synthase, vi) an inhibitor of PLA2 enzyme; vii) an anti-proliferative agent; viii) an anti-oxidant; ix) an apoptosis inhibitor selected from the group consisting of EPO mimetic peptides, EPO mimetibodies, IGF-I, IGF-II, and caspase inhibitors, and x) an inhibitor of MMPs; and xi) an inhibitor of p38 kinase.
摘要:
The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.
摘要:
The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.
摘要:
The present invention provides a method of diagnosing the presence or severity of tissue fibrosis in an individual by detecting α2-macroglobulin (α2-MG) in a sample from the individual; detecting hyaluronic acid (HA) in a sample from the individual; detecting tissue inhibitor of metalloproteinases-1 (TIMP-1) in a sample from the individual; and diagnosing the presence or severity of tissue fibrosis in the individual based on the presence or level of α2-MG, HA and TIMP-1.